glycyrrhizic acid has been researched along with resveratrol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Muriel, P; Rivera-Espinoza, Y | 1 |
Deng, Y; Feng, Z; Huang, Y; Lian, B; Wang, L; Wu, M; Wu, W; Zhao, X; Zhong, C; Zu, C | 1 |
Abdelaziz, GM; Abu El-Asrar, AM; Ahmad, A; De Hertogh, G; Mohammad, G; Siddiquei, MM | 1 |
1 review(s) available for glycyrrhizic acid and resveratrol
Article | Year |
---|---|
Beneficial drugs for liver diseases.
Topics: Adrenal Cortex Hormones; Animals; Colchicine; Curcumin; Disease Models, Animal; Drug Combinations; Glycyrrhizic Acid; Humans; Interferons; Liver Diseases; Nitric Oxide; Plant Extracts; Resveratrol; S-Adenosylmethionine; Silymarin; Stilbenes; Thalidomide | 2008 |
3 other study(ies) available for glycyrrhizic acid and resveratrol
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Delayed-Action Preparations; Drug Delivery Systems; Glycyrrhizic Acid; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice; Nanoparticles; Resveratrol; Serum Albumin, Human; Stilbenes | 2017 |
Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
Topics: Animals; Anti-Inflammatory Agents; Blood-Retinal Barrier; Blotting, Western; Dextrans; Diabetic Retinopathy; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Epiretinal Membrane; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glycyrrhizic Acid; HMGB1 Protein; Humans; Immunohistochemistry; Intravitreal Injections; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol; Sirtuin 1; Vitreous Body | 2019 |